December 2005 Vol.16;12

(1) Autotopes and Allotopes

(2)Novel Mechanism of P-Fimbriated Escherichia coli Virulence in Polynephritis

(3)Race and Kidney Disease Outcomes: Genes or Environment?

November 2005 Vol.16;11

(1) More Targeted Treatment for Lupus Nephritis: Is the Future (Nearly) Here?

(2)Towards a Definition and Classification of Acute Kidney Injury

October 2005 Vol.16;10

(1) Molecular Physiology of Renal Acquaporins and Sodium Transporters: Exciting Approaches to Understand Regulation of Renal Water Handling

(2)Role of Podocytes in Focal Sclerosis: Defining the Point of No Return

(3)Intravenous Iron: How Much, Is Too Much?

September 2005 Vol.16;9

(1) JASN Public Access Policy

(2)Thrombotic Microangiopathy;The Nex Big Hurdle for Xenotransplantation

(3)Mechanisms and Fetal Origins of Kidney Disease

August 2005 Vol.16;8

(1) Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy: It's All the RAGE

(2)Asymmetric Dimethylarginine and Kidney Disease--Marker or Mediator?

July 2005 Vol.16;7

(1) Rapamycin: A New String to the Antiproteinuric Bow?

(2)Assoction of Metabolic Syndrome in Non Diabetic Patients with Increased Risk for Chronic Kidney Disease: The Fat Lady Sings

(3)Albuminuria, Just A Marker for Cardiovascular Disease, Or Is It More?

June 2005 Vol.16;6

(1) Regulating Renal Drug Elimination?

(2)Linking Metabolism and Immunology: Diabetic Nephropathy in an Inflammatory Disease

(3)Beyond Framingham: Cardiovascular Risk Profiling in ESRD

May 2005 Vol.16;5

(1) Medicare ESRD Porspective Payment System: Weighing the Evidence

(2)An You Thought the Age of Anatomic Discovery Was Over

(3)Tipping the Balance in Glomerulonephritis

April 2005 Vol.16;4

(1) Uniform Clinical Trial Registration Policy for Journals of Kidney Diseases, Dialysis, and Transplantation

(2)V2 Receptor Antagonists in Cystic Kidney Diseases:An Exciting Step Towards a Practical Treatment

(3)Is Regression of Chronic Nephropathies a Therapeutic Target?

(4)Cardiovascular Risk Evaluation before Kidney Transplantation

March 2005 Vol.16;3

(1) Type 2 Diabetic Nephropathy:Never too Early to Treat?

February 2005 Vol.16;2

(1) Uroguanylin: Physiological Role as a Natriuretic Hormone

(2)Calcification or Classification?

January 2005 Vol.16;1

(1) The New JASN

(2)Wound Healing in the Kidney: Complex Interactions in the Renal Interstitial Fibrogenesis

(3)Acute Renal Failure and Cardiac Suregry:Marching in Place or Moving Ahead?